PH22014000055U3 - A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption - Google Patents

A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption

Info

Publication number
PH22014000055U3
PH22014000055U3 PH2/2014/000055U PH22014000055U PH22014000055U3 PH 22014000055 U3 PH22014000055 U3 PH 22014000055U3 PH 22014000055 U PH22014000055 U PH 22014000055U PH 22014000055 U3 PH22014000055 U3 PH 22014000055U3
Authority
PH
Philippines
Prior art keywords
vitamin
composition
containing calcium
supplement containing
better absorption
Prior art date
Application number
PH2/2014/000055U
Other versions
PH22014000055Y1 (en
Inventor
Cheng Edison
Original Assignee
Bewell Nutraceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bewell Nutraceuticals Corp filed Critical Bewell Nutraceuticals Corp
Priority to PH2/2014/000055U priority Critical patent/PH22014000055U3/en
Publication of PH22014000055Y1 publication Critical patent/PH22014000055Y1/en
Publication of PH22014000055U3 publication Critical patent/PH22014000055U3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A composition for a vitamin supplement containing calcium, vitamin C and vitamin D3 for better absorption comprising: 400-500 mg Calcium Ascorbate, 400-500 mg calcium citrate and 1.0-2.0 mcg Vitamin D3.
PH2/2014/000055U 2014-02-07 2014-02-07 A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption PH22014000055U3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH2/2014/000055U PH22014000055U3 (en) 2014-02-07 2014-02-07 A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH2/2014/000055U PH22014000055U3 (en) 2014-02-07 2014-02-07 A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption

Publications (2)

Publication Number Publication Date
PH22014000055Y1 PH22014000055Y1 (en) 2014-10-01
PH22014000055U3 true PH22014000055U3 (en) 2014-12-05

Family

ID=52580880

Family Applications (1)

Application Number Title Priority Date Filing Date
PH2/2014/000055U PH22014000055U3 (en) 2014-02-07 2014-02-07 A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption

Country Status (1)

Country Link
PH (1) PH22014000055U3 (en)

Also Published As

Publication number Publication date
PH22014000055Y1 (en) 2014-10-01

Similar Documents

Publication Publication Date Title
PT3456717T (en) Tablets containing 4,6-diamino-quinoline-3-carbonitrile derivatives as cancer osaka thyroid (cot) modulators for treating cancer
MX2016016593A (en) Novel aminoalkyl benzothiazepine derivative and use thereof.
MY187540A (en) Compounds active towards bromodomains
MX370792B (en) Methods and compositions for the treatment of cancer.
MX2018002543A (en) Compositions comprising urolithin compounds.
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
GB2541571A (en) Pharmaceutical compositions
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
AU2015299431B2 (en) Pyrrolidinone derivatives as metAP-2 inhibitors
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
PH12016501841A1 (en) Immunosuppressant formulation
EP4289820A3 (en) Compounds for use in treating alzheimer's disease in apoe4+/+ patients
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2018007737A (en) Fruit chew supplements.
WO2016080796A3 (en) Pharmaceutical composition, containing sesquiterpene compound, for preventing or treating stat3-mediated diseases, and use thereof
MX2016005545A (en) Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same.
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
EP3270883A4 (en) Scalable vitamin composition unit dosage for the treatment of fat-soluble vitamin deficiencies
GB2543709A (en) Pharmaceutical agent
EP3235808A4 (en) Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same
EP3097918A4 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
PH22014000055U3 (en) A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption
PH12016501647B1 (en) Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency
PH22014000539U3 (en) A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption